Tag: COVID-19 and Monoclonal Antibodies

Ask the Doctor Question: When do you except the FDA to approve monoclonal antibody therapy for CLL patients? Answer: We are monitoring the situation closely and have been in contact with FDA officials behind the scenes to push them to make

Ask the Doctor Question: I am a 72-year-old woman with no other health issues, except CLL, in my fifth day of COVID. Have been taking Imbruvica for five-years which has worked wonderfully for me. As it appears I have a

Ask the Doctor Question: What is the status of AstraZeneca’s EUA request for their COVID monoclonal antibody shot as a preventative for CLL patients? If approved, would this be for pre-exposure use? Also, if AstraZeneca has had enough testing to

Ask the Doctor Question: Can you discuss the compassionate use paperwork and logistics for getting the Regeneron Regen-COV infusions? Would it be possible to start the process sooner? Who should I speak with about receiving Regen-COV? Answer: CLL Society is aware

Ask the Doctor Question: Are you recommending pre-exposure prophylactic IV monoclonal antibodies for severely immunocompromised CLL patients? Will insurance cover this? Answer: The only treatment that is approved for this (yet) is Regeneron’s product called Regen-COV. And the emergency authorization has